Given that IDO2 expression was not correlated with the pathologic grades of glioma, it was deduced that the expression and activity of IDO1/TDO increased with the pathologic grades of glioma, and both IDO1 and TDO were involved in the malignancy of glioma. This evidence concerns the gene IDO2 and central nervous system cancer.